|
|
|
|
|
by ZeroGravitas
632 days ago
|
|
In the article the drug maker suggestss that rather than negotiate the price down, US insurers stop buying the drug if he cuts the price too low. That seems like a wild claim to make, but since it's just reported as if that was normal rather than a shocking scandal, I guess it's probably true. |
|